* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Aspen Pharmacare Holdings's PEG Ratio or its related term are showing as below:
APNHF'
s PEG Ratio Range Over the Past 10 Years
Min: 0.55 Med: 1.32 Max: 13.95
Current: 2.71
During the past 13 years, Aspen Pharmacare Holdings's highest PEG Ratio was 13.95. The lowest was 0.55. And the median was 1.32.
APNHF's PEG Ratio is ranked worse than 67.02% of 373
companies
in the Drug Manufacturers industry
Industry Median: 1.65
vs APNHF: 2.71
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Aspen Pharmacare Holdings PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Aspen Pharmacare Holdings's PEG Ratio
For the Drug Manufacturers - Specialty & Generic subindustry, Aspen Pharmacare Holdings's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aspen Pharmacare Holdings's PEG Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Aspen Pharmacare Holdings's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Aspen Pharmacare Holdings's PEG Ratio falls into.
Aspen Pharmacare Holdings PEG Ratio Calculation
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio.
The ratio we use is the 5-Year EBITDA growth rate.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Aspen Pharmacare Holdings (OTCPK:APNHF) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Aspen Pharmacare Holdings PEG Ratio Related Terms
Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Aspen Pharmacare Holdings (Aspen Pharmacare Holdings) Business Description
Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
APNHF has been successfully added to your 